Risk Partners Life Sciences Roundtable 2024, thank you very much! Already for the 26.06.2025 >

Contact us
Your Risk.
 Our DNA.

With Atrialis - experts for clinical trials, we have been successfully supporting our clients in the market since 2007. With the founding of Risk Partners in 2023, we have significantly expanded our range of services once again. We are specialized and aim to be the market leader in these specializations for game changers. Accordingly, we are regularly involved in important topics for you or network with important trendsetters in our specializations. We are happy to keep you up to date with our developments so that you can regularly read new articles here.  

Our contributions
Question is unanswered?

News from Risk Partners -
For you in our specialist areas

Whistleblower Protection Act

Whistleblower Protection Act ... is now in force. Hey #VCs, do you already have a system in place for safe #whistleblowing? And what about insurance cover in your D&O insurance? One month ago today, the German Whistleblower Protection Act came into force. Since July 2, 2023, not only companies with more than 50 employees, but also fund managers and ManCos (capital management companies in accordance with Section 17 (1) of the German Investment Code) have been obliged to set up and operate a whistleblower system, regardless of

Read more "
October 31, 2023

13th Hamburg Financial Lines Forum

Risk Partners at the Financial Lines Forum 13th Hamburg Financial Lines Forum. On October 12 and 13, the 13th Hamburg Financial Lines Forum took place with the participation of Risk Partners, a traditional event that this year once again served as a forum for the exchange of current trends. The program began with an overview of current developments and the handling of claims in financial lines, presented by Gabriele Schreiber-Sahin, Michael Hendricks. Dr.

Read more "
October 28, 2023

Cyber Risks: Case Study Evotec

Last year, more than 10 percent of German companies were affected by an IT security incident, with the proportion rising due to cyber attacks. Biotechnology is not excluded either. It is possible to learn from the Evotec case. It is about successful cyber attacks or other incidents that are important for security, such as acts of sabotage or hardware theft. According to a representative Ipsos survey conducted on behalf of the TÜV association among 501 companies with more

Read more "
October 22, 2023

St. Gallen study: USD 6 billion per drug

HSG St. Gallen: Drug costs USD 6.16 billion on average. Are the days of new drugs costing less than USD 1 billion over? There were figures in the industry that spoke of USD 700-1,000 million as the cost of developing a new drug. A study by the University of St. Gallen covering the period 2001-2020 found that the cost of developing new drugs has risen dramatically. It was estimated that

Read more "
September 26, 2023

Known from:

pates-podcast-recruiting-dna-cover-1024x1024
platform_life_sciences_logo
Road to IPO _ by digital kompakt & Deutsche Börse
Venture_Capital_white_blue_frame
transcript_logo_rp
Logo Venture Mate
ROTIPO-Road-to-IPO-Boerse-1536x1536
Podcast_5

You have questions -
we solve them!

1

Your question to us

We are highly specialized, so we can tell you immediately whether this is within our area of expertise (e.g. fire insurance for a sawmill is not), a D&O program for a NASDAQ listing is.

Book desired date
2

Advice & proposed solution

As an independent insurance broker, we work with all insurers relevant to our specializations in the continental European and UK markets - one of our USPs. As part of our consultation, we discuss with you the optimal marketing strategy for your risk for our tender.

Franziska Merz

Senior Risk Advisor Financial Lines

3

Market comparison & recommendation

Depending on your requirements, e.g. D&O insurance via one insurer or a structured program with 10 insurers, we will present you with the possibilities of the market based on our customer-friendly product developments (e.g. Risk Partners D&O Prime Protect 2024) without obligation.

Does our proposal solve your issue? You decide whether we should implement our proposal for you.

4

Promise of care

Your risk changes (e.g. new financing round) or the insurance market changes, we discuss with you possible adjustment options or urgent need for change. Claims? You call us first and we take over for you at eye level with the insurers.
Risk Partners, your insurance experts!